CD40 antibody (PerCP-Cy5.5)
Quick Overview for CD40 antibody (PerCP-Cy5.5) (ABIN7674262)
Target
See all CD40 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- PerCP-Cy5.5 Anti-Human CD40 Antibody
-
Purification
- 0
-
Purity
- 0
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Volume per test: 5μL. Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0. 1 % sodium azide, 1 % BSA, pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- CD40
-
Alternative Name
- CD40
-
Background
-
Synonyms: Bp50|CD40L receptor|CDw40|TNFRSF5
Background: CD40 is a 48 kD type I glycoprotein also known as BP50. It is a member of the TNFR superfamily primarily expressed on B cells, macrophages, follicular dendritic cells, endothelial cells, fibroblasts, and at low levels on plasma cells. CD40 has been reported to be involved in B cell differentiation, costimulation, isotype class-switching, and protection of B cells from apoptosis. Additionally, CD40 is important for T cell-B cell interactions. The ligand of CD40 is CD154 (CD40 ligand).
-
Molecular Weight
- 0
-
Gene ID
- 958
-
UniProt
- P25942
-
Pathways
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-